Stock Report

Global Health Limited (Medanta) Reports Q1 FY27 Results: Consolidated Revenue Surges 26.5% YoY to ₹1,304.05 Crore

Posted On : 2026-07-31 13:22:34( TIMEZONE : IST )

Global Health Limited (Medanta) has published its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026 (Q1 FY27). The healthcare provider registered strong top-line revenue growth across its hospital operations year-on-year, supported by steady expansion in total income.

Consolidated Financial Performance

On a consolidated basis, Global Health reported a 26.50% year-on-year increase in Revenue from Operations, climbing to ₹1,304.05 crore (₹13,040.51 million) for Q1 FY27, compared to ₹1,030.84 crore (₹10,308.44 million) in the corresponding quarter of the previous fiscal year (Q1 FY26).

Total consolidated income for the quarter reached ₹1,326.22 crore (₹13,262.15 million), marking a 26.15% growth against ₹1,051.29 crore (₹10,512.94 million) recorded in Q1 FY26.

Profit Before Exceptional Items & Tax: Increased to ₹213.26 crore (₹2,132.63 million) in Q1 FY27, up 13.11% from ₹188.55 crore (₹1,885.49 million) in Q1 FY26.

Profit After Tax (PAT): Came in at ₹157.25 crore (₹1,572.52 million), compared to ₹158.98 crore (₹1,589.82 million) in Q1 FY26.

PAT Attributable to Owners: Profit after tax attributable to the owners of the holding company stood at ₹158.73 crore (₹1,587.27 million), compared to ₹159.01 crore (₹1,590.09 million) in the year-ago period. Non-controlling interests accounted for a loss of ₹1.48 crore.

Total Expenses: Total consolidated expenses for the quarter rose to ₹1,112.95 crore (₹11,129.52 million) from ₹862.75 crore (₹8,627.45 million) in Q1 FY26. Key cost components included employee benefits expense of ₹319.27 crore, cost of materials consumed at ₹257.19 crore, and retainers and consultants fee at ₹200.73 crore.

Total Comprehensive Income: Total comprehensive income attributable to owners of the holding company reached ₹153.57 crore (₹1,535.65 million) for Q1 FY27.

Standalone Financial Results

On a standalone basis, Global Health delivered consistent operational growth:

Revenue from Operations: Advanced 22.28% year-on-year to ₹1,078.72 crore (₹10,787.23 million) in Q1 FY27, compared to ₹882.16 crore (₹8,821.56 million) in Q1 FY26.

Total Income: Rose 21.81% year-on-year to ₹1,102.78 crore (₹11,027.83 million) against ₹905.30 crore (₹9,052.95 million) in Q1 FY26.

Profit Before Exceptional Items & Tax: Stood at ₹183.11 crore (₹1,831.10 million), up from ₹178.65 crore (₹1,786.54 million) in Q1 FY26.

Profit After Tax (PAT): Reported at ₹137.31 crore (₹1,373.07 million) for Q1 FY27, compared to ₹151.96 crore (₹1,519.64 million) in Q1 FY26.

Total Expenses: Increased to ₹919.67 crore (₹9,196.73 million) from ₹726.64 crore (₹7,266.41 million) in the year-ago quarter.

Earnings Per Share & Share Capital

Consolidated EPS: Basic Earnings Per Share for Q1 FY27 stood at ₹5.91 per share (face value of ₹2.00 each), compared to ₹5.92 in Q1 FY26. Diluted EPS was reported at ₹5.90.

Standalone EPS: Basic EPS for Q1 FY27 came in at ₹5.11 per share, compared to ₹5.66 in Q1 FY26, with diluted EPS at ₹5.10.

Paid-Up Share Capital: Paid-up equity share capital stood at ₹53.75 crore (₹537.54 million) with a face value of ₹2.00 per share.

Shares of Global Health Limited was last trading in BSE at Rs. 1415.60 as compared to the previous close of Rs. 1432.60. The total number of shares traded during the day was 7500 in over 691 trades.

The stock hit an intraday high of Rs. 1430.85 and intraday low of 1395.10. The net turnover during the day was Rs. 10569199.00.